Posted on August 13, 2018 by Sitemaster
A newly published review by staff of the Center for Devices and Radiological Health (CDRH at the U.S. Food & Drug Administration (FD) addresses the potential role for patient preference information (PPI) in determining patient perceptions of the “value” of high-intensity focused ultrasound (HIFU) and similar techniques in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: approval, benefit, devices, FDA, HIFU, information, medical, patient, preference, risk | Leave a comment »
Posted on April 30, 2018 by Sitemaster
An interesting article has just been published in the Journal of Urology which helps to provide information (and context) about the quality of data supporting the use of high-intensity focused ultrasound (HIFU) in the treatment of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: choice, effectiveness, focused, HIFU, high-intensity, patient, preference, safety, ultrasound | 6 Comments »
Posted on December 14, 2017 by Sitemaster
Current guidelines from the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the National Comprehensive Cancer Network (NCCN) all clearly state that, for men diagnosed with low-risk prostate cancer, active surveillance is an appropriate form of first-line management. However, … … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, function, preference, sexual, surveillance | 7 Comments »
Posted on September 12, 2017 by Sitemaster
In another presentation from the ESMO meeting in Madrid, Spain, Fizazi et al. presented data from the randomized CABA-DOC trial exploring patients’ preferences for either docetaxel or cabazitaxel as a first-line form of chemotherapy. … READ MORE …
Filed under: Management, Treatment | Tagged: cabazitaxel, chemotherapy, choice, docetaxel, preference, taxane | 2 Comments »
Posted on January 17, 2015 by Sitemaster
The question of whether men should be regularly screened for risk of prostate cancer through the use of the PSA test is (at least) controversial … READ MORE …
Filed under: Diagnosis, Risk | Tagged: choice, discrete, preference, PSA, risk, screening | 5 Comments »
Posted on August 28, 2013 by Sitemaster
It has been a while since we saw data from a contemporary survey of the views of urologists and patients on their preferences for appropriate management of early stage, localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Management, patient, preference, urologist | 5 Comments »
Posted on September 25, 2012 by Sitemaster
The degree to which individual patients with prostate cancer wish to participate in making decisions about their treatment varies considerably, and it is important for health professionals to understand the degree to which each individual patient wants to be an active participant in these decisions. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: decision-making, outcome, preference, quality of life, Treatment | 3 Comments »
Posted on March 2, 2009 by Sitemaster
New reports today address:
- Positive surgical margins: RALP vs. RRP
- Circulating tumor cells levels and survival of castration-resistant prostate cancer patients
- Patient preference and management of post-surgical incontinence … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: circulating tumor cell, CTC, incontinence, positive surgical margin, preference, prostatectomy, RALP, RRP | 4 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 